Skip to main content
Top

Current Treatment Options in Oncology

Issue 4/2014

Content (13 Articles)

Neuro-oncology (GJ Lesser, Section Editor)

Patient Reported Endpoints for Measuring Clinical Benefit in (High Grade Glioma) Primary Brain Tumor Patients

Terri S. Armstrong, Mark R. Gilbert

Neuro-oncology (GJ Lesser, Section Editor)

Therapeutic Decision Making in Patients with Newly Diagnosed Low Grade Glioma

Adesh Tandon, David Schiff

Neuro-oncology (GJ Lesser, Section Editor)

Treatment of Radiation-Induced Cognitive Decline

Albert Attia, Brandi R. Page, Glenn J. Lesser, Michael Chan

Neuro-oncology (GJ Lesser, Section Editor)

Current Role of Anti-Angiogenic Strategies for Glioblastoma

Alissa A. Thomas, Antonio Omuro

Neuro-oncology (GJ Lesser, Section Editor)

Therapeutic Strategies for Cancer Treatment Related Peripheral Neuropathies

Deirdre R. Pachman, James C. Watson, Charles L. Loprinzi

Neuro-oncology (GJ Lesser, Section Editor)

Management of Pediatric and Adult Patients with Medulloblastoma

Allison M. Martin, Eric Raabe, Charles Eberhart, Kenneth J. Cohen

Head and Neck Cancer (J-P Machiels, Section Editor)

Human Papillomavirus-Associated Oropharynx Cancer (HPV-OPC): Treatment Options

Nicole G. Chau, Guilherme Rabinowits, Robert I. Haddad

Head and Neck Cancer (J-P Machiels, Section Editor)

The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck

Marc Hamoir, Sandra Schmitz, Vincent Gregoire

Head and Neck Cancer (J-P Machiels, Section Editor)

Interventional Pulmonologist Perspective: Treatment of Malignant Pleural Effusion

Andrew J. Sweatt, Arthur Sung

Lung Cancer (HA Wakelee, Section Editor)

The Minority Report: Targeting the Rare Oncogenes in NSCLC

Caroline E. McCoach, Robert C. Doebele

Lung Cancer (HA Wakelee, Section Editor)

Immune Checkpoint Inhibitors in NSCLC

Douglas B. Johnson, Matthew J. Rioth, Leora Horn

Lung Cancer (HA Wakelee, Section Editor)

c-MET Inhibitors in the Treatment of Lung Cancer

Joanna Goździk-Spychalska, Katarzyna Szyszka-Barth, Łukasz Spychalski, Katarzyna Ramlau, Jerzy Wójtowicz, Halina Batura-Gabryel, Rodryg Ramlau

Lung Cancer (HA Wakelee, Section Editor)

Local and Systemic Therapies for Malignant Pleural Mesothelioma

Daniel Gomez, Anne S. Tsao

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine